Non Obstructive Versus Obstructive Coronary Artery Disease

February 13, 2023 updated by: Hasanain Ali Al ftailah, Arab Board of Health Specializations, Iraq

Non Obstructive Versus Obstructive Coronary Artery Disease Documented by Coronary Angiography; Prevalence & Diagnostic Features in a Single Center Experience : A Prospective Cross Sectional Study

The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . The main question[s] it aims to answer are:

  • how it different from classical type of ischemic heart disease ( obstructive coronary artery disease)
  • what is frequency and age prevalence of these patient Participants evaluated by history , clinical examination, serum troponin and coronary angiography.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

167

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Iraq
      • Karbala, Iraq, 56001
        • Arab board of health specializations-Iraq, Karbala , Iraq

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 81 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all patients with clinical features of IHD underwent coronary angiography in CCU of imam hussain hospital from January to May of 2021

Description

Inclusion Criteria:

  • Patients diagnosed with IHD ( MI, unstable angina ,chronic stable angina)
  • >18 years of age
  • patients undergoing CAG for emergency or elective situations.

Exclusion Criteria:

  • Patients who were hemodynamically unstable.
  • patients with incomplete data
  • patients with clinical features of pericarditis or others of non cardiac origin chest pain .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non obstructive versus obstructive coronary artery disease documented by coronary angiography; prevalence & diagnostic features in a single center experience : A prospective cross sectional study
Time Frame: BASELINE
analysis of diagnostic features and frequency of non obstructive artery disease in comparison to obstructive artery disease
BASELINE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Arab Board of Health Specializations, Iraq

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

February 11, 2023

Study Registration Dates

First Submitted

February 13, 2023

First Submitted That Met QC Criteria

February 13, 2023

First Posted (Estimate)

February 22, 2023

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NOCAD diagnostic features

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-Obstructive Coronary Artery Disease

Clinical Trials on CORONARY ANGIOGRAPHY

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe